Innovating.works Conecta tu I+D

Showing 1 to 20 of 33 results

QCEED: Quantum Dot coupling engineering and dynamic spin decoupling deep nuclei cooling 2 dimensional cl... The overarching objective of QCEED is to find solutions to current bottlenecks to photonic quantum information processing. Scalable photonic...
2024-10-25 - 2029-01-31 | Financiado

PREDICT: PREDICT PRoviding Effective longitudinal models of RAS DIrect inhibition to Combat Tumor resistance DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2024-POC Problem: In 2022, more than half a million lung cancer patients worldwide carrying KRAS mutations faced therapy resistance, a trend on the r...
2024-10-07 - 2026-06-30 | Financiado

CATSYNEX: Harnessing the Market Potential of Single Atom Catalysts through Next Generation Large Scale Synthes... DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2024-POC The CATSYNEX project, born from the ERC-StG SAC_2.0 project, addresses the pressing need for scalable production of single-atom catalysts to...
2024-08-09 - 2026-04-30 | Financiado

Core: A Multi fidelity Approach Enabling Automated High Precision in Cold Spray Repair DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2024-POC "The EU's manufacturing sector is facing a crucial challenge to achieve ambitious sustainability goals in the transition towards a circular...
2024-08-08 - 2026-06-30 | Financiado

TNext: Tellurene Memristors for Neuromorphic Computing System Technology DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2024-POC Big-data management is currently placing a high demand on both the hardware performance level, e.g. access latency, storage capacity, cost p...
2024-07-19 - 2026-03-31 | Financiado

easi-IPMN: Early Inflammatory Signatures of IPMN Progression DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2023-POC Pancreatic Ductal Adenocarcinoma (PDAC) is a lethal cancer with rising global incidence and poor survival rates. Early PDAC diagnosis is ham...
2024-04-23 - 2025-10-31 | Financiado

UNMASK: Unraveling Parkinson´s disease diagnostic DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2023-POC Parkinson´s disease (PD) is a progressive, chronic, and debilitating neurodegenerative disease for which there is no cure and no diagnostic...
2024-04-03 - 2025-12-31 | Financiado

OxyBatt: High-temperature oxygen batteries for Industrial Internet of Things DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: HORIZON-EIC-2023-TRANSITION-01 The project OxyBatt addresses a pressing need for portable energy storage in the intermediate temperature range. Currently, no battery techn...
2024-03-22 - 2027-04-30 | Financiado

hiPSCmore: Instrumented human stem cells to see more during high throughput screening in drugInstrumented human... DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2023-POC "In hiPSCmore (read hiP-See-More), my team and I will engineer fluorescent sensors in the DNA of human induced pluripotent stem cells (hiPSC...
2024-02-29 - 2025-10-31 | Financiado

PROFTH: PROstate Focal THerapy DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2023-POC The PROFTH project aims at developing the robotics and AI technologies to enable focal therapies for prostate cancer (PCa) using the robotic...
2023-10-31 - 2025-06-30 | Financiado

MABank: Creation of a GLP bank of immune-privileged, immortal mesoangioblasts to treat monogenic, recessive... DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2023-POC Stem cells led to effective cures for diseases of blood and epithelia. However, in the case of diseases affecting muscles, connective tissue...
2023-08-31 - 2025-02-28 | Financiado

SludgeCam: A smart centrifuge camera for testing dewatering ability of waste-water sludges in hyper-gravity DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2022-POC2 The EU produces more than 45000 tons of waste-water sludge per day as byproduct of municipal and industrial water purification activities. T...
2023-04-11 - 2024-10-31 | Financiado

ARIA: Validation of Magnet-Free Wireless Charging and Communication for Intra-body Devices DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2022-POC2 Cochlear implants (CIs), which electrically stimulate the auditory nerve to repair hearing in people with severe-to-profound hearing loss, a...
2023-03-15 - 2024-09-30 | Financiado

AcouSome: Acoustofluidic thin-film actuated chip for exosome separation from blood DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 AcouSome is a consortium stemming from the ongoing EIC-FET Open BioWings project, and consists of four of the BioWings project partners (Aco...
2022-11-11 - 2025-12-31 | Financiado

ASTEASIER: Novel and sustainable biotechnological approaches for astaxanthin and ketocarotenoids production DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 Microalgae are photosynthetic unicellular microorganisms which can be cultivated at industrial level and adopted as sustainable platforms to...
2022-10-26 - 2024-12-31 | Financiado

ABuMic: All-acoustic Bubble Microrheology for rapid screening of formulations DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2022-POC2 ABuMic aims to address a critical challenge of our society: the transition of formulated products to a safer and more sustainable industry....
2022-06-30 - 2023-12-31 | Financiado

ENSURE: Non-invasive follow-up of urinary tract cancers DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2022-POC1 Bladder cancer is the most common malignancy of the urinary tract with 573,000 new cases and 213,000 deaths in 2020 worldwide and affecting...
2022-06-20 - 2024-06-30 | Financiado

NEXUS: automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: HORIZON-EIC-2021-TRANSITIONOPEN-01 The NEXUS project will develop an easily customizable integrated platform to enable Extracellular Vesicles (EVs) separation, purification an...
2022-05-19 - 2025-05-31 | Financiado

ResisCHIP: Rapid chip-based detection of antibiotic resistances DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: ERC-2022-POC1 Drug-resistant infections are one of the greatest threats facing humanity. Antimicrobial resistance (AMR) causes over 700.000 deaths each ye...
2022-05-17 - 2023-11-30 | Financiado

PRISMA: MICRO-MECHANICAL PUMP FOR NEXT GENERATION INSULIN DELIVERY SYSTEMS DAY ONE SOCIETA A RESPONSABILITA LIMITATA participó en un HORIZON EUROPE: HORIZON-EIC-2021-TRANSITIONOPEN-01 PRISMA is a revolutionary thin-film micropump realized with novel ceria-based oxides actuating materials in the frame of the FET-OPEN BioWin...
2022-03-30 - 2025-06-30 | Financiado